The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -72.41%.However, over the last six months, we can see a stronger performance of -80.00%. Over the last 30 days, the price of IBO has leaped by -51.22%. And in the last five days, it has fallen by -5.88%.
52-week price history of IBO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Impact BioMedical Inc’s current trading price is -93.52% away from its 52-week high, while its distance from the 52-week low is 8.11%. The stock’s price range during this period has varied between$0.37 and $6.17. The Impact BioMedical Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.46 million for the day, a figure considerably lower than their average daily volume of 6.16 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Impact BioMedical Inc (IBO) has experienced a quarterly decline of -78.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.60M and boasts a workforce of 2 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4813, with a change in price of -1.9900. Similarly, Impact BioMedical Inc recorded 3,835,337 in trading volume during the last 100 days, posting a change of -83.26%.
IBO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IBO stands at 2.08. Similarly, the long-term debt-to-equity ratio is also 0.00.
IBO Stock Stochastic Average
Impact BioMedical Inc’s raw stochastic average for the past 50 days is presently 0.52%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 4.29%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 5.51% and 5.57%, respectively.
